Broadly neutralizing antibodies targeting the HIV-1 envelope V2 apex confer protection against a clade C SHIV challenge.
Loading...
Date
Journal Title
Journal ISSN
Volume Title
Publisher
American Association for the Advancement of Science.
Abstract
Abstract available in pdf.
Description
CAPRISA, 2017.
Citation
Julg, B., Tartaglia, L.J., Keele, B.F., Wagh, K., Pegu, A., Sok, D., Abbink, P., Schmidt, S.D., Wang, K., Chen, X., Joyce, M.G., Georgiev, I.S., Choe, M., Kwong, P.D., Doria-Rose, N.A., Le, K., Louder, M.K., Bailer, R.T., Moore, P.L., Korber, B., Seaman, M.S., Abool Karim, S.S., Morris, L., Koup, R.A., Mascola, J.R., Burton, D.R. and Barouch, D.H. 2017. Broadly neutralizing antibodies targeting the HIV-1 envelope V2 apex confer protection against a clade C SHIV challenge. Science Translational Medicine 9(406), eaal1321.